Jabra Enhance Select 300 vs Signia Pure C&G BCT IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.
Choice

Jabra Enhance Select 300
The Jabra Enhance Select 300 is a premium OTC hearing aid priced at $1,695 that earns an A grade with a SoundScore of 4.1/5 in our lab testing. This behind-the-ear device ranks #17 out of 65 OTC hearing aids tested, placing it in the top 25% of its category. In our standardized testing, speech clarity in quiet environments stands out as a notable strength, scoring 3.6/5—a solid result that sits 0.85 points above the category average. Feedback handling is excellent at 5.0/5, meaning users should experience stable performance without whistling during typical wear. Own-voice comfort also performs well at 3.5/5, nearly a full point above average, which can contribute to a more natural listening experience. Speech understanding in noisy environments presents a limitation, scoring 1.5/5—essentially at the category average but low in absolute terms. This is a common challenge across OTC devices, though users seeking strong noise performance may want to compare alternatives. Music streaming scores 2.6/5, which is above the category average by 0.68 points but mixed in absolute quality. The Enhance Select 300 offers rechargeable batteries and streaming compatibility with both iPhone and Android devices, along with hands-free functionality. It has earned Expert's Choice Awards in both 2023 and 2024. Shoppers in this price range should note that alternatives like the Lucid Tala and Audicus Omni 2 score higher overall, while options like the Jabra Enhance Pro 20 at Costco offer similar sound quality at a lower price point. This device is best suited for those prioritizing speech clarity in quieter settings and stable, feedback-free performance.
Choice

Signia Pure C&G BCT IX
The Signia Pure C&G BCT IX is a premium prescription behind-the-ear hearing aid released in 2025, priced at $3,398. In our lab testing, it earned an A grade with a SoundScore of 4.4/5, placing it in the top 39% of the 36 prescription hearing aids we've tested. This device shows notable strengths in speech clarity and own-voice comfort. Speech in quiet scored 3.8/5, which is 0.47 points above the category average—a solid result for everyday conversations. Speech in noise measured 2.5/5, above the category average by 0.58 points, though only mixed in absolute terms, meaning challenging listening environments may still present difficulty. Own-voice comfort is a standout at 3.8/5, a full 1.05 points above average, suggesting reduced occlusion effects that many wearers find bothersome. Feedback handling scored 4.2/5—strong in absolute terms, though 0.51 points below the category average of 4.71/5. Music streaming at 2.7/5 is essentially on par with category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Consumers shopping in this premium price tier should note that several alternatives offer higher overall scores, including the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5). For those prioritizing own-voice comfort and solid speech performance in quieter settings, the Pure C&G BCT IX delivers, but buyers seeking top-tier noise performance may want to compare options.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit